|
|
|
|
|
|
A conversation with John Stubenrauch and Sam Deutsch, Nutcracker Therapeutics | Nutcracker's unique approach to scaling up to clinical manufacturing — which brings unique challenges compared to traditional biologics — relies on microfluidics. |
|
|
|
| Optimizing Autologous Cell Therapy Clinical Trials | e-book | By Karen Ivester, RN, MA, inSeption Group | Delve into four articles regarding dissecting the critical resources, processes, and key stakeholders essential for the successful completion of an ACT clinical trial. |
|
|
|
|
| A Full-Service Outsourcing Partner with 97% Customer Retention | inSeption Group offers a full-service solution designed to disrupt the current outsourcing paradigm, resurrecting a common-sense approach to rebuild business trust and confidence in a client’s selected vendor. Primarily focused on oncology, hematology, neurodegenerative disorders, and rare/orphan disease indications, with a specialization in cell and gene therapy, inSeption has been a solution for its’ clients who have experienced the progressive degradation of today’s outsourcing options. Contact them. |
|
|
|
|
|
.png){kind=logo}
